347 related articles for article (PubMed ID: 10500341)
1. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
Landesman KA; Stozek M; Freeman NJ
Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
3. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
Marsà Carretero M; Alos Manrique C; Valles Callol JA
Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
[No Abstract] [Full Text] [Related]
5. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Jones PH; Davidson MH
Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
[TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
SantaCruz PL; González A; León ME; Fernández MY
Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
[No Abstract] [Full Text] [Related]
7. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.
Marais GE; Larson KK
Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197
[No Abstract] [Full Text] [Related]
9. [Interactions between statins and macrolide antibiotics].
Molden E; Andersson KS; Jacobsen D
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1660-1. PubMed ID: 17571108
[No Abstract] [Full Text] [Related]
10. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
11. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
[TBL] [Abstract][Full Text] [Related]
12. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
[TBL] [Abstract][Full Text] [Related]
13. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.
Kahri AJ; Valkonen MM; Vuoristo MK; Pentikäinen PJ
Ann Pharmacother; 2004 Apr; 38(4):719. PubMed ID: 14966253
[No Abstract] [Full Text] [Related]
16. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil.
Knoll RW; Ciafone R; Galen M
Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847
[No Abstract] [Full Text] [Related]
17. Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin.
Grunden JW; Fisher KA
Ann Pharmacother; 1997; 31(7-8):859-63. PubMed ID: 9220046
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
19. Severe rhabdomyolysis associated with the cerivastin-gemfibrozil combination therapy: report of a case.
Lau TK; Leachman DR; Lufschanowski R
Tex Heart Inst J; 2001; 28(2):142-5. PubMed ID: 11453128
[TBL] [Abstract][Full Text] [Related]
20. Baycol withdrawn from market.
SoRelle R
Circulation; 2001 Aug; 104(8):E9015-6. PubMed ID: 11521677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
